Laboratory management of CIN 2: The consensus is consensus

American Journal of Clinical Pathology

Volumn 130, Issue 2, 2008, Pages 162-164

  Crum, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CANCER SURGERY; CRYOTHERAPY; CYTODIAGNOSIS; EDITORIAL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LASER SURGERY; OUTPATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA IN SITU;

BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONSENSUS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; OBSERVER VARIATION; REFERRAL AND CONSULTATION;

EID: 48649104308     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/GCVB5C4KFV7TFC7F     Document Type: Editorial

References (21)

1. Dürst M, Gissmann L, Ikenberg H, et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983;80:3812-3815.
2. Crum CP, Ikenberg H, Richart RM, et al. Human papillomavirus type 16 and early cervical neoplasia. N Engl J Med. 1984;310:880-883.
3. Duensing S, Münger K. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer. 2004;109:157-162.
4. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97:1072-1079.
5. Wetchler SJ. Treatment of cervical intraepithelial neoplasia with the CO2 laser: laser versus cryotherapy: s review of effectiveness and cost. Obstet Gynecol Surv. 1984;39:469-473.
6. Prendiville W, Cullimore J, Norman S. Large loop excision of the transformation zone (LLETZ): a new method of management for women with cervical intraepithelial neoplasia. Br J Obstet Gynaecol. 1989;96:1054-1060.
7. Wright TC Jr, Massad LS, Dunton CJ, et al; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346-355.
8. Genest DR, Stein L, Cibas E, et al. A binary (Bethesda) system for classifying cervical cancer precursors: criteria, reproducibility, and viral correlates. Hum Pathol. 1993;24:730-736.
9. Stoler MH, Schiffman M; Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285:1500-1505.
10. Crum CP. Symposium part 1: should the Bethesda System terminology be used in diagnostic surgical pathology? Point. Int J Gynecol Pathol. 2003;22:5-12.
11. Crum CP, Rose PG. Cervical squamous neoplasia. In: Crum CP, Lee KR, eds. Diagnostic Gynecologic and Obstetric Pathology. Philadelphia, PA: Saunders; 2006:290-315.
12. Burghardt E. Early Histologic Diagnosis of Cervical Cancer. Philadelphia, PA: Saunders; 1973.
13. Koutsky LA, Ault KA, Wheeler CM, et al; Proof of Principle Study Investigators. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002;347:1645-1651.
14. Crum CP, Beach KJ, Hedley ML, et al. Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol. J Infect Dis. 2004;189:1348-1354.
15. McLachlin CM, Shen LH, Sheets EE, et al. Disparities in mean age and histopathologic grade between human papillomavirus type-specific early cervical neoplasms. Hum Pathol. 1997;28:1226-1229.
16. Carreon JD, Sherman ME, Guillén D, et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol. 2007;26:441-446.
17. Galgano MT, Castle PE, Stoler MH, et al. Can HPV-16 genotyping provide a benchmark for cervical biopsy specimen interpretation? Am J Clin Pathol. 2008;130:65-70.
18. Crum CP, Mitao M, Levine RU, et al. Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. J Virol. 1985;54:675-681.
19. Crum CP, Lee K, Hirsch M, et al. Comparison of the histopathologic diagnosis of CIN2 and CIN3, cytology and HPV testing: results from the pivotal amolimogene trial in high-grade cervical intraepithelial neoplasia. Abstract presented at the American Society of Colposcopy and Cervical Pathology meeting; March 18, 2008; Orlando, FL.
20. Cai B, Ronnett BM, Stoler M, et al. Longitudinal evaluation of interobserver and intraobserver agreement of cervical intraepithelial neoplasia diagnosis among an experienced panel of gynecologic pathologists. Am J Surg Pathol. 2007;31:1854-1860.
21. Baak JP, Kruse AJ, Janssen E, et al. Predictive testing of early CIN behaviour by molecular biomarkers. Cell Oncol. 2005;27:277-280.